Urol. praxi. 2022;23(3):143-148 | DOI: 10.36290/uro.2022.039

Sexual dysfunction - diagnostics and solution options

MUDr. Igor Dolan, Ph.D., MUDr. Petr Filipenský, Ph.D.
Urologické oddělení, Fakultní nemocnice u sv. Anny v Brně

Sexual dysfunction (SD) means a quantitative or qualitative disorder that makes it impossible to have a satisfying sex life. Although it is sometimes possible to prove a clearly organic or psychogenic etiology, they usually have a multifactorial origin. Primary SD occurs in the patient from the beginning of sexual life, secondary SD appears after a certain longer trouble- free period. Generalized SD is not tied to the current partnership, selective is tied to a particular partnership and its quality. The prevalence of SD in the population is not exactly known; in a survey of the sexual behavior of a representative sample of the Czech population in 2008, 20 % of men and women alike stated that they sometimes suffered from a certain sexual dysfunction.

Keywords: sexual dysfunction, diagnostics, therapy.

Accepted: October 10, 2022; Published: October 12, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dolan I, Filipenský P. Sexual dysfunction - diagnostics and solution options. Urol. praxi. 2022;23(3):143-148. doi: 10.36290/uro.2022.039.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sexual and reproductive health [Internet]. [cited 2022 Jan 22]. Available from: http://uroweb.org/guidelines.
    2. Weiss P, Zvěřina J. Sexuální chování české populace. Urolog. praxi. 2009;10(3):160-163.
    3. Šrámková T. Poruchy sexuality u somaticky nemocných a jejich léčba. Praha: Grada; 2013.
    4. Capogrosso P, et al. One patient out of four with newly diagnosed erectile dysfunction is a young man - worrisome picture from the everyday clinical practice. J Sex Med. 2013;10:1833-1841. Go to original source... Go to PubMed...
    5. Šrámková T. Sexuologie pro zdravotníky. Praha: Galén; 2015.
    6. Zámečník a kol. Moderní farmakoterapie v urologii. Praha: Maxdorf; 2019.
    7. Kratochvíl S. Sexuální dysfunkce 3., doplněné a aktualizované vydání. Praha: Grada; 2008.
    8. Bittner L, Zámečník L. Naše první zkušenosti s implantací penilních protéz. Urol. praxi. 2018;19(3):133-135. Go to original source...
    9. Vardi Y, et al. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243. Go to original source... Go to PubMed...
    10. Kitrey ND, Vardi Y, Appel B, et al. Low Intensity Shock Wave Treatment for Erectile Dysfunction - How Long Does the Effect Last? J Urol. 2018;200(1):167-70. Go to original source... Go to PubMed...
    11. Al Demour S, Jafar H, Adwan S, et al. Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial. Urol Int. 2018;101(3):358-65. Go to original source... Go to PubMed...
    12. Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59(1):61-5. Go to original source... Go to PubMed...
    13. Gacci M, et al. Impact of medical treatments for male lower urinary tract symptoms due to Benign prostatic hyperplasia on ejaculatory function : a systematic review and meta-analysis, J Sex Med. 2014;11:1554. Go to original source... Go to PubMed...
    14. Meissne, VH, et al. Factors Associated with Low Sexual Desire in 45-Year-Old Men: Findings from the German Male Sex-Study. J Sex Med. 2019;16:981. Go to original source... Go to PubMed...
    15. Goldstein I, Kim NN, Clayton AH, et al. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc. 2017;92(1):114-128. Go to original source... Go to PubMed...
    16. Jolly E, Thorp J, Clayton AH, et al. Patients' Perspective of Efficacy of Flibanserin in Premenopausal Women with HSDD. Oral presentation at the 58th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists, May 2010].
    17. Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.